Chemesis International Inc. to Cultivate and Manufacture for Puerto Rican CBD Market
Chemesis, Inc. (CSE: CSI) (OTC: CADMF) (FRA:CWAA)
Chemesis International Inc. to Cultivate and Manufacture for Puerto Rican CBD Market
Natural Ventures will cultivate and manufacture CBD products for the Puerto Rican medical cannabis market
January 24, 2018
Vancouver, BC – Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (FRA: CWAA) (the “Company” or
“Chemesis”), announces its subsidiary Natural Ventures will enter the CBD market. The U.S. CBD market
could surge to $845 million by 2019, and over $ 2 billion by 20221. With the passing of the 2018 Farm Bill
the federal CBD market will allow U.S. territories su ch as Puerto Rico to ship its hemp derived products
across state lines and into markets across the US.
Natural Ventures has begun cultivating high potency CBD strains, and anticipates full production
capabilities by Q2 2019. The Company was able to crossb reed genetics which allowed for an increased
CBD concentration and the seed strains have been fully registered with the Puerto Rican Health
Department. Furthermore, the subsidiary holds all necessary licenses to cultivate and manufacture
hemp derived finish goods.
With infrastructure already in place, Natural Ventures will be able to effectively add CBD products
alongside its currently available finished goods. The Company anticipates the roll out of products into
dispensaries across Puerto Rico by Q2 2019 . Initial products will include tinctures, balms , vape pens and
sprays.
“Patients in Puerto Rico know and trust the Natural Ventures brand,” said CEO, Edgar Montero “The
Company believes this relationship with patients will give us a head start and allow u s to enter the CBD
market effectively and our existing relationships will ensure we are able to quickly get our products on
the shelves of dispensaries around the island”
On Behalf of The Board of Directors
Edgar Montero
CEO and Director
About Chemesis International Inc.
Chemesis International Inc. is a vertically integrated global leader in the cannabis industry, currently
operating within California, Puerto Rico, and Colombia.
Chemesis is developing a strong foothold in key markets, from cultivation, to manufacturing, distribution
and retail. Chemesis has facilities in both Puerto Rico and California, allowing for cost effective
1 Financial Post
Chemesis, Inc. (CSE: CSI) (OTC: CADMF) (FRA:CWAA)
production and distribution of its products. In addition, Chemesis leverages exclusive brands and
partnerships and uses the highest quality extraction methods to provide consumers with quality
cannabis products.
Chemesis will add shareholder value by exploring opportunities in emerging markets while consistently
delivering quality product to its consumers from seed to sale.
Investor Relations:
1 (604) 398-3378
Social Media:
Chemesis.facebook
Chemesis.twitter
Chemesis.instagram
DesertZen.instagram
CaliforniaSap.instagram
Jay&SB.instagram
Forward-Looking Information: This news release contains "forward -looking information" within the meaning of
applicable securities laws relating to statements regarding the Company's business, products and future of the
Company’s business, its product offerings and plans for sales and marketing, includi ng finalizing an acquisition in
Colombia. Although the Company believes that the expectations reflected in the forward -looking information are
reasonable, there can be no assurance that such expectations will prove to be correct. Readers are cautioned not to
place undue reliance on forward -looking information. Such forward -looking statements are subject to risks and
uncertainties that may cause actual results, performance and developments to differ materially from those
contemplated by these statements depe nding on, among other things, the risks that the Company's products and
plan will vary from those stated in this news release and the Company may not be able to carry out its business
plans as expected. Except as required by law, the Company expressly disc laims any obligation and does not intend
to update any forward -looking statements or forward -looking information in this news release. Although the
Company believes that the expectations reflected in the forward -looking information are reasonable, there ca n be
no assurance that such expectations will prove to be correct and makes no reference to profitability based on sales
reported. The statements in this news release are made as of the date of this release.
The CSE has not reviewed, approved or disapproved the content of this press release